Scientific Background Klow Blend is a composite vial containing four well-characterised synthetic peptides under investigation for distinct yet complementary biochemical pathways: GHK-Cu (copper-binding tripeptide), BPC-157 (Body Protection Compound-157), TB-4 (Thymosin Beta-4 fragment), and KPV (Lys-Pro-Val tripeptide)
A cohort study used exenatide twice daily as an additional agent in patients who experienced failure in metformin treatment
F.KobayashiE.et al (1991)
The review included a total of 170 randomized controlled trials totaling 14,223 people
It is of note that, consistently upon injury induction, the BPC 157-treated rats regularly exhibited fast function recovery (i.e., lack of leg contracture) (i.e., [43,44,45,46,47,48,93,94,95,96,97,98])